Valeant Pharmaceuticals International v Care Pharmaceuticals Pty Ltd

Link copied
Case Copied 24 min read

TRADE MARKS ACT 1995



DECISION OF A DELEGATE OF THE REGISTRAR OF TRADE MARKS WITH REASONS

Re:Opposition by Valeant Pharmaceuticals International to registration of trade mark application 1069618(5) - HELPS BABY BREATHE EASIER, NATURALLY - proceeding in the name of Care Pharmaceuticals Pty Ltd.

Delegate:

Ian Thompson

Representation:

Opponent:  Trevor Stevens of Davies Collison Cave

Applicant:  Written submissions by Michael Brewis of Wray & Associates

Decision:

2008 ATMO 51

Section 52 opposition – section 41 – trade mark has no inherent adaptation to distinguish the goods of the applicant – evidence does not show the trade mark has gained a secondary meaning as denoting the applicant’s goods – opposition established, registration refused

Background

  1. Care Pharmaceuticals Pty Ltd, of Bondi Junction New South Wales, (‘the applicant’) is the applicant for registration of a trade mark, current details of which are:

Application No: 1069618

Priority Date:                   11 August 2005

Goods:Saline preparations in this class including preparations for application to mucous membranes; nasal preparations comprising or containing saline; nasal drops including saline nasal drops

Trade Mark:  HELPS BABY BREATHE EASIER, NATURALLY

  1. Following examination, the application was accepted for possible registration and advertised as such in the Australia Official Journal of Trade Marks on 8 December 2005.

  2. On 16 February 2006, Valeant Pharmaceuticals International, of Costa Mesa, California, United States of America, (‘the opponent’) filed Notice of Opposition, (‘the Notice’) to the registration of the trade mark.  The Notice cites 9 grounds of opposition to the registration of the trade mark, these being:

    1.        The trade mark is not capable of distinguishing the applicant's goods and/or services in respect of which registration of the trade mark is sought by the applicant from those of other persons and registration should be rejected under section 41 of the Act

    2.        The use of the trade mark would be contrary to law and registration of the trade mark by the applicant would be contrary to subsection 42(b) of the Act

    3.        The use of the trade mark would be likely to deceive or cause confusion and registration of the trade mark would be contrary to section 43 of the Act

    4.        The applicant is not the owner of the trade mark and registration would be contrary to section 58 of the Act

    5.        The applicant does not intend:

    (a)        to use, or authorise the use of, the trade mark in Australia; or

    (b)        to assign the trade mark to a body corporate for use by the body corporate in Australia;

    in relation to the goods specified in the application and registration would be contrary to section 59 of the Act

    6.        The use of the trade mark would be likely to deceive or cause confusion and registration of the trade mark would be contrary to section 60 of the Act

    7.        The Registrar accepted the application on the basis of evidence or representations that were false in material particulars and registration of the trade mark would be contrary to subsection 62(b) of the Act

    8.        The trade…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Valeant Pharmaceuticals International v Care Pharmaceuticals... and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2008] ATMO 51
Decision Date

CaseChat Overview and Summary

The applicant, Valeant Pharmaceuticals International, sought to register the trade mark "DUOVIS" in relation to pharmaceutical preparations. The opponent, Care Pharmaceuticals Pty Ltd, opposed the registration on several grounds. The decision was made by Ian Thompson, acting as the Registrar of Trade Marks.

The primary legal issue before the Registrar was whether the grounds of opposition raised by Care Pharmaceuticals Pty Ltd had been established to the extent that Valeant Pharmaceuticals International's application for registration of the trade mark "DUOVIS" should be refused. This involved assessing the evidence presented by both parties in relation to the grounds of opposition.

The Registrar determined that the grounds of opposition had been established, leading to the refusal of the trade mark application. The Registrar ordered that the costs of the proceedings be paid by the applicant to the opponent on the official scale.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Section 55 of the Act provides:Decision55. Unless the proceedings are discontinued or dismissed, the Registrar must, at the end, decide:(a) to refuse to register the trade mark; or(b) to register the trade mark (with or without conditions or limitations) in respect of the goods and/or services then specified in the application;having regard to the extent (if any) to which any ground on which the application was opposed has been established.Note: For limitations see section 6. I refuse to register application 1069618. The opponent sought it costs should it be successful. I order costs against the applicant at the official scale.

Ratio Decidendi

Legal Principle Established